Cibc World Market Inc. purchased a new stake in shares of Amrize Ltd (NYSE:AMRZ – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 8,780 shares of the company’s stock, valued at approximately $423,000.
Several other institutional investors and hedge funds also recently made changes to their positions in AMRZ. State of Wyoming bought a new stake in Amrize in the 3rd quarter worth about $32,000. Costello Asset Management INC bought a new position in shares of Amrize in the third quarter worth about $44,000. Global Retirement Partners LLC bought a new stake in Amrize during the 3rd quarter worth approximately $48,000. Jones Financial Companies Lllp bought a new stake in shares of Amrize during the 3rd quarter valued at $53,000. Finally, BNP Paribas Financial Markets purchased a new position in shares of Amrize in the second quarter valued at about $59,000.
Amrize Trading Up 10.9%
NYSE:AMRZ opened at $63.66 on Thursday. The stock has a market capitalization of $35.21 billion and a price-to-earnings ratio of 34.60. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $64.84. The company has a quick ratio of 0.97, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The firm has a 50 day moving average of $55.76 and a 200 day moving average of $52.30.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on the stock. Weiss Ratings raised shares of Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, February 11th. Deutsche Bank Aktiengesellschaft set a $59.00 price objective on Amrize in a research note on Monday, December 8th. Stephens began coverage on shares of Amrize in a report on Friday, November 14th. They set an “overweight” rating and a $60.00 price target on the stock. Wall Street Zen raised Amrize to a “hold” rating in a research report on Saturday, October 25th. Finally, Royal Bank Of Canada lowered shares of Amrize from an “outperform” rating to a “sector perform” rating and raised their target price for the stock from $56.00 to $60.00 in a research report on Monday, December 8th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $60.75.
View Our Latest Research Report on Amrize
Key Stories Impacting Amrize
Here are the key news stories impacting Amrize this week:
- Positive Sentiment: Company proposed a shareholder-return package: $1.0B repurchase authorization plus a $0.44 special dividend and a $0.44 annual dividend, supporting upside via capital returns. Amrize jumps 11% on Q4 results, upbeat 2026 outlook, and new shareholder return plan
- Positive Sentiment: Q4 EPS beat: reported $0.62 vs. $0.59 est., and the firm generated strong operating and free cash flow, which lowers leverage and funds returns/investment. Amrize Q4 Earnings Call Highlights
- Positive Sentiment: 2026 guidance raised: revenue growth guided ~4–6% and adjusted EBITDA growth ~8–11%, signaling operational momentum into the year. Amrize rises on 2026 EBITDA outlook, $1bn buyback after Q4 miss
- Positive Sentiment: Closed acquisition of PB Materials adds 26 operating sites and long-lived aggregates reserves in West Texas — expands scale in a high-growth region and supports long-term demand. Amrize Closes Acquisition of PB Materials; Aggregates Leader in High-Growth West Texas
- Neutral Sentiment: Form 10‑K filed for FY2025 highlighting $11.8B revenue and North American scale — useful confirmation of results and disclosures but not a directional surprise. Amrize Files 2025 Form 10-K, Highlighting $11.8 Billion in Revenue and North American Scale
- Neutral Sentiment: Unusual options activity: a surge in call purchases suggests short-term bullish positioning from some traders, adding to intraday volume/volatility. (reported activity)
- Neutral Sentiment: Jefferies issued a Hold — a reminder that some brokers remain cautious on valuation or near-term upside despite the positive actions. Amrize Ltd (AMRZ) Receives a Hold from Jefferies
- Negative Sentiment: Revenue for the quarter missed consensus ($2.84B reported vs. ~$2.95B expected), which is a near-term headwind and explains some analyst caution. Amrize Ltd (AMRZ) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Amrize Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
See Also
- Five stocks we like better than Amrize
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
